NM

Nirmalya Mukherjee

Active Director Designated Partner DIN 11724084
DIN 11724084 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirmalya Mukherjee

Data last updated:

Nirmalya Mukherjee is a Designated Partner at Qonixka Pharma Llp (since 2026).

DIN 11724084
Primary Designation Designated Partner
First Appointment 16 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 May 20262026Active

Board colleagues of Nirmalya Mukherjee

NameDINCompanyDesignation
Avijit Barat11724085Qonixka Pharma LlpDesignated Partner
Pijush Gorai11724083Qonixka Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Qonixka Pharma Llp
Premium access

Shareholding and investment profile for Nirmalya Mukherjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmalya Mukherjee

Nirmalya Mukherjee currently holds 1 directorship: Qonixka Pharma Llp (Designated Partner, since 16 May 2026).

Nirmalya Mukherjee was first appointed on 16 May 2026 as Designated Partner at Qonixka Pharma Llp.

The current boards of Nirmalya Mukherjee's companies include Avijit Barat (Qonixka Pharma Llp), Pijush Gorai (Qonixka Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available